CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Restricted Stock	Options and Restricted Stock	Total	Common Stock	Common Stock Options and Restricted Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Additional Paid-in Capital Restricted Stock	Additional Paid-in Capital Options and Restricted Stock	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive (Loss) Income	Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2019						95,600,000
Balance at beginning of period at Dec. 31, 2019		$ (300)			$ 767,400	$ 1,000		$ 323,600				$ 489,400	$ (300)	$ (22,400)	$ (24,200)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2019															1,500,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Acquisition of treasury stock (in shares)															(1,100,000)
Acquisition of treasury stock	$ (22,200)														$ (22,200)
Exercise of stock options	200							(400)							$ 600
Compensatory awards released from restriction (in shares)															1,200,000
Compensatory awards released from restriction	0							(19,800)							$ 19,800
Share-based compensation	10,900							10,900
Stock dividends	(100)											(100)
Cash dividends	(1,900)											(1,900)
Foreign currency translation equity adjustment	25,700													25,700
Change in fair value of derivative instruments, net of tax	(9,800)													(9,800)
Equity component of convertible notes, net of issuance costs and tax	57,100							57,100
Capped call premium confirmations, net of tax	(24,500)							(24,500)
Net income (loss)	(126,900)											(126,900)
Balance at end of period (in shares) at Dec. 31, 2020						95,600,000
Balance at end of period at Dec. 31, 2020					675,600	$ 1,000		346,900				360,200		(6,500)	$ (26,000)
Treasury stock, balance at end of period (in shares) at Dec. 31, 2020															1,400,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued during period (in shares)						89,800,000	200,000
Common stock issued during period	2,650,200			$ 0		$ 900	$ 0	2,649,300			$ 0
Acquisition of treasury stock (in shares)															(1,400,000)
Acquisition of treasury stock	(38,100)							400							$ (38,500)
Exercise of stock options (in shares)						600,000									900,000
Exercise of stock options	22,300							1,800							$ 20,500
Compensatory awards released from restriction (in shares)						0									900,000
Compensatory awards released from restriction	0							(18,500)							$ 18,500
Share-based compensation	38,700		$ 33,000					38,700		$ 33,000
Foreign currency translation equity adjustment	(29,200)													(29,200)
Change in fair value of derivative instruments, net of tax	8,400													8,400
Net income (loss)	$ 322,000											322,000
Balance at end of period (in shares) at Dec. 31, 2021						186,200,000
Balance at end of period at Dec. 31, 2021		$ (44,700)			3,682,900	$ 1,900		3,051,600	$ (57,100)			682,200	$ 12,400	(27,300)	$ (25,500)
Treasury stock, balance at end of period (in shares) at Dec. 31, 2021	1,000,000														1,000,000.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06
Acquisition of treasury stock (in shares)															(1,600,000)
Acquisition of treasury stock	$ (35,800)							300							$ (36,100)
Exercise of stock options (in shares)	100,000														100,000
Exercise of stock options	$ 700							(700)							$ 1,400
Compensatory awards released from restriction (in shares)															1,200,000
Compensatory awards released from restriction	0							(29,000)							$ 29,000
Share-based compensation	47,000							47,000
Foreign currency translation equity adjustment	(44,700)													(44,700)
Change in fair value of derivative instruments, net of tax	10,500													10,500
Issuance of common stock related to convertible notes	500							500
Capped call transaction related to convertible note conversion	0							100							(100)
Net income (loss)	$ 157,900											157,900
Balance at end of period (in shares) at Dec. 31, 2022						186,200,000
Balance at end of period at Dec. 31, 2022					$ 3,774,300	$ 1,900		$ 3,012,700				$ 852,500		$ (61,500)	$ (31,300)
Treasury stock, balance at end of period (in shares) at Dec. 31, 2022	1,300,000														1,300,000